Our previous studies show that in estrogen-stimulated MCF-7 breast cancer cells, raloxifene at low concentrations (1 or 4 μM) evoked an antiestrogenic effect on collagen biosynthesis and prolidase activity, while an estrogenic effect on gelatinolytic activity. This evidence concerns the gene PEPD and breast carcinoma.